160 related articles for article (PubMed ID: 36322931)
21. A
Wang CP; Ferreira JE; Placek A; Aguayo-Hiraldo P; Raca G; Wood BL; Miller KP; Coates T; Freyer DR; Kovach AE
Leuk Lymphoma; 2024 May; ():1-5. PubMed ID: 38733629
[TBL] [Abstract][Full Text] [Related]
22. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
Hyde RK; Liu P; Friedman AD
Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
[TBL] [Abstract][Full Text] [Related]
23. Hereditary leukemia due to rare RUNX1c splice variant (L472X) presents with eczematous phenotype.
Sorrell A; Espenschied C; Wang W; Weitzel J; Chu S; Parker P; Saldivar S; Bhatia R
Int J Clin Med; 2012 Dec; 3(7):. PubMed ID: 24353905
[TBL] [Abstract][Full Text] [Related]
24. A novel RUNX1 exon 3 - 7 deletion causing a familial platelet disorder.
Almazni I; Chudakou P; Dawson-Meadows A; Downes K; Freson K; Mason J; Page P; Reay K; Myers B; Morgan NV;
Platelets; 2022 Feb; 33(2):320-323. PubMed ID: 33616470
[TBL] [Abstract][Full Text] [Related]
25. Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations.
Toratani K; Watanabe M; Kanda J; Oka T; Hyuga M; Arai Y; Iwasaki M; Sakurada M; Nannya Y; Ogawa S; Yamada T; Takaori-Kondo A
Int J Hematol; 2023 Sep; 118(3):400-405. PubMed ID: 36897502
[TBL] [Abstract][Full Text] [Related]
26. Genomic Landscape of Patients with Germline
Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
bioRxiv; 2023 Jan; ():. PubMed ID: 36789433
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
[TBL] [Abstract][Full Text] [Related]
29. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
[TBL] [Abstract][Full Text] [Related]
31. Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice.
Ahmad MH; Hegde M; Wong WJ; Mohammadhosseini M; Garrett L; Carrascoso A; Issac N; Ebert B; Silva JC; Pihan G; Zhu LJ; Wolfe SA; Agarwal A; Liu PP; Castilla LH
Blood Adv; 2023 Dec; 7(23):7304-7318. PubMed ID: 37756546
[TBL] [Abstract][Full Text] [Related]
32. An Old Dog Has a New Trick: Somatic Exonic Deletions in RUNX1 Are Frequent in AML.
Chakraborty J; Stengel KR
Clin Cancer Res; 2023 Aug; 29(15):2742-2744. PubMed ID: 37289016
[TBL] [Abstract][Full Text] [Related]
33. RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity.
Chin DW; Sakurai M; Nah GS; Du L; Jacob B; Yokomizo T; Matsumura T; Suda T; Huang G; Fu XY; Ito Y; Nakajima H; Osato M
Blood Cancer J; 2016 Jan; 6(1):e379. PubMed ID: 26745853
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Mendler JH; Maharry K; Radmacher MD; Mrózek K; Becker H; Metzeler KH; Schwind S; Whitman SP; Khalife J; Kohlschmidt J; Nicolet D; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
J Clin Oncol; 2012 Sep; 30(25):3109-18. PubMed ID: 22753902
[TBL] [Abstract][Full Text] [Related]
35. [Familial leukemia due to germline RUNX1 mutations: lessons learned from two decades of research and unsolved problems].
Osato M; Nambu A
Rinsho Ketsueki; 2020; 61(6):687-696. PubMed ID: 32624544
[TBL] [Abstract][Full Text] [Related]
36. Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.
Cavalcante de Andrade Silva M; Krepischi ACV; Kulikowski LD; Zanardo EA; Nardinelli L; Leal AM; Costa SS; Muto NH; Rocha V; Velloso EDRP
Cancer Genet; 2018 Apr; 222-223():32-37. PubMed ID: 29666006
[TBL] [Abstract][Full Text] [Related]
37. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
[TBL] [Abstract][Full Text] [Related]
38. Distinctive phenotypes in two children with novel germline
Bagla S; Regling KA; Wakeling EN; Gadgeel M; Buck S; Zaidi AU; Flore LA; Chicka M; Schiffer CA; Chitlur MB; Ravindranath Y
Pediatr Hematol Oncol; 2021 Feb; 38(1):65-79. PubMed ID: 32990483
[No Abstract] [Full Text] [Related]
39. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.
Gaidzik VI; Bullinger L; Schlenk RF; Zimmermann AS; Röck J; Paschka P; Corbacioglu A; Krauter J; Schlegelberger B; Ganser A; Späth D; Kündgen A; Schmidt-Wolf IG; Götze K; Nachbaur D; Pfreundschuh M; Horst HA; Döhner H; Döhner K
J Clin Oncol; 2011 Apr; 29(10):1364-72. PubMed ID: 21343560
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
Harada Y; Harada H
J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
